From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Chiroscience Group Plc
Traded asformerly on the London Stock Exchange
FateAcquired by Celltech
Founded1991; 28 years ago (1991)[1]
Defunct1999 (1999)
Key people
John Padfield CEO, 1996[2]

Chiroscience Group Plc was a British-based biotech company, founded by Christopher Evans. The company was taken over by Celltech in 1999[3], which was acquired in 2004 by UCB.

Chiroscience was born from the demise of the company Enzymatix, which was ultimately acquired by Genzyme,[4] when Andy Richards joined the company and convinced Evans and Peter Keen to launch Chiros, which name was quickly revised to Chrioscience.[3] Seed funding for the company of GB£3 million was provided by Schroder Ventures, Apax and 3i.[3] Chiroscience became one of the first biotechnology Initial Public Offerings in the United Kingdom in 1994.[3]

In 1996, the company merged with the American biotech company Darwin Molecular Corporation, based in Cambridge, Massachusetts, retaining Chiroscience as its name.[2]

By the time of its merger with Celltech in 1999,[5] both Chris Evans and Peter Keen had left the company, leaving Andy Richards as the sole remaining founder and member of the original management board.[3]

See also[edit]

References and notes[edit]

  1. ^ Start year has been reported also as 1992. See Springett 1996 citation.
  2. ^ a b Springett, Pauline (November 21, 1996). "Chiroscience buys Darwin". The Guardian. p. 22. Retrieved December 24, 2018 – via
  3. ^ a b c d e f Quested, Tony (June 7, 2015). "Cream of life science entrepreneurs' first venture was selling doughnuts". Business Weekly. Cambridge, England: Q Communications. Retrieved December 24, 2018.
  4. ^ "Genzyme Corp". International Directory of Company Histories. 2006 – via
  5. ^ The companies were of roughly equal valuation when the merger took place.
  6. ^ "Focus Chiroscience". The Guardian. London, England: Guardian Newspapers, Ltd. May 7, 1999. Retrieved December 24, 2018.
  7. ^ Choi, Audrey (November 16, 1995). "Research is taming the 'bad side' of medicines". Honolulu Star-Bulletin. 84 (274). Originally from The Wall Street Journal. p. A-9. Retrieved December 24, 2018.

Further reading[edit]

  • Datastream (May 8, 1996). "Chiroscience on the up". The Guardian. London, England. p. 21. Retrieved December 24, 2018 – via This shows performance of stock from May 1995 to May 1996.
  • Murphy, Paul (April 26, 1996). "Market report". The Guardian. London, England. p. 20. Retrieved December 24, 2018 – via On Mr. Buffet's terms, Chiroscience is nothing more than a bag of dreams. Contains a graphic showing company stock performance across 1994 to 1996.

External links[edit]